Back to Trades
Bruns Ingmar
Chief Medical OfficerCIK 0001838041
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2026
Across 2 filings between 2026, Bruns Ingmar, Chief Medical Officer, has disclosed $1.0M in transactions — all concentrated in Zentalis Pharmaceuticals, Inc. (ZNTL). Their disclosed trades are heavily weighted toward selling — $0 in buys and $8.0K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Feb 10 | ZNTL Zentalis Pharmaceuticals, Inc. | Bruns Ingmar | Chief Medical Officer | Sell | $8.0K |
| Jan 9 | ZNTL Zentalis Pharmaceuticals, Inc. | Bruns Ingmar | Chief Medical Officer | Award | $1.0M |
2 filings